Originated by VidaPeps LLC, which attests it authorized this test as the brand of record.
Axiom confirmed this brand is a registered Axiom account. This does not confirm the product's origin, chain of custody, or that the brand authorized this specific test.
- L1Identity
- L2Purity
- L3Net Peptide Content
- L4Sterility (USP <71>)
- L5Endotoxin
- L6Heavy Metals
- L7Stability
- L8Fentanyl Screen
Test Results
Select a test for its full result| Test | Reference standard | Result | Verdict |
|---|---|---|---|
| Referencewithin ±1 Da of 4731.41 Da | Result4731.28 Da (error -0.13 Da) | PASS | |
| Referenceat least 98% | Result99.92% | PASS | |
| Referencewithin ±10% of the 15 mg label claim | Result15.37 mg (+2.49%) | PASS | |
| ReferenceUSP <71> | ResultNo Growth | PASS | |
| Reference≤ 0.5 EU/mg (USP 85) | Result0 EU/mg | PASS | |
| ReferenceUSP <232>/<233> limits | ResultAll below limits | PASS | |
| ReferencepH within 5.50 - 7.50 and degradation below 5% | ResultpH 6.24, 2% degradation at 24 h | PASS | |
| Referenceno fentanyl or analog at or above 1 ng/mg | Resultnone detected | PASS |
REPORTING SCOPE & LIMITATIONS
- [Fentanyl Screen]Targeted LC-MS/MS adulterant screen, reported as detected or not detected against its stated detection limit. A harm-reduction research screen, not an exhaustive adulterant panel.
Results relate only to the item or portion tested. Unless sampling was performed or witnessed by Axiom Analytics, the laboratory does not attest that the submitted sample represents the wider lot or batch. A PASS designation means only that the reported result met the specification shown. It does not establish safety, efficacy, regulatory approval, legality, or suitability for human or animal use.
All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.
Physical instrument analysis is performed within Axiom Analytics' laboratory network, allocated at Axiom's discretion based on method, capacity, and order volume. Axiom Analytics performs sample accession, chain of custody, analytical oversight, and data review, and issues and is responsible for this certificate. Where analysis is subcontracted, the method is performed within the partner laboratory's published ISO/IEC 17025 scope of accreditation for that method, not merely at a laboratory holding ISO/IEC 17025 accreditation. Axiom Analytics does not itself currently hold ISO/IEC 17025 accreditation. The method-validation status of each reported result is identified beside that result. Partner laboratory identities are not disclosed: samples are analyzed under double-blind conditions, identified only by an internal lot ID.
To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind (including but not limited to direct, indirect, special, incidental, punitive, or consequential damages) shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.